Literature DB >> 2784662

Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy.

P J Wallis1, K S Ryatt, T J Constable.   

Abstract

A case of Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriasis and psoriatic arthropathy is described. This potentially fatal event was probably precipitated by an interaction between methotrexate and concurrent non-steroidal anti-inflammatory drugs, resulting in serious potentiation of the effects of methotrexate.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2784662      PMCID： PMC1003730          DOI： 10.1136/ard.48.3.247

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  7 in total

1.  The effect of organic acids on renal clearance of methotrexate in man.

Authors:  D G Liegler; E S Henderson; M A Hahn; V T Oliverio
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

2.  Interaction between methotrexate and non-steroidal anti-inflammatory drugs.

Authors:  H Daly; J Boyle; C Roberts; G Scott
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

3.  Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis.

Authors:  J L Perruquet; T M Harrington; D E Davis
Journal:  Arthritis Rheum       Date:  1983-10

Review 4.  Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.

Authors:  A Nyfors
Journal:  Dan Med Bull       Date:  1980-04

5.  Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Feldman; R J Aur; M S Verzosa; H O Hustu; J V Simone
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen.

Authors:  A Thyss; G Milano; J Kubar; M Namer; M Schneider
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

7.  Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding.

Authors:  J R Taylor; K M Halprin
Journal:  Arch Dermatol       Date:  1977-05
  7 in total
  7 in total

1.  Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone.

Authors:  D Clerc; C Brousse; X Mariette; P Bennet; M Bisson
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

Review 2.  Corticosteroid sparing agents in asthma.

Authors:  J M Hill; A E Tattersfield
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 3.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

Review 4.  Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

Authors:  S Tariq; S M Tariq
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

Review 5.  Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

Authors:  A Wollner; J Mohle-Boetani; R E Lambert; J L Perruquet; T A Raffin; J L McGuire
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

6.  Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.

Authors:  L M Kuitert; A C Harrison
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

7.  Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype.

Authors:  Malene Knarborg; Ole Hilberg; Hans-Jürgen Hoffmann; Ronald Dahl
Journal:  Eur Clin Respir J       Date:  2014-11-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.